| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 3.20 | Intermediate level resistance | Recombinant | Details | Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007) | ||
| Cidofovir | 2.60 | Low level resistance | Recombinant | Details | Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007) | ||
| Foscarnet | 4.30 | Intermediate level resistance | Recombinant | Details | Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens. (Nov 2007) |
| Mutant | Resistances |
|---|---|
| G841S |
Ganciclovir:
|
| G841S |
Cidofovir:
|
| G841S |
Foscarnet:
|